YinJia Biotech develops a protein research and development platform utilizing computer simulation, artificial intelligence, and Cell Free Protein Selective (CFPS) technologies to create high-quality protein-based biomaterials and reagents. Their products are designed for early cancer diagnosis, personalized medication guidance, and new drug development, addressing critical needs in the biomedicine sector.
Funding
Funding not disclosed
Founders
Product
Problem
The development of high-quality protein-based biomaterials and reagents is often hindered by inefficient and time-consuming traditional methods. Existing protein research and development processes can lack the precision and speed required for early cancer diagnosis, personalized medication guidance, and new drug development.
Solution
YinJia Biotech offers a protein research and development platform that integrates computer simulation, artificial intelligence (AI), and Cell Free Protein Selective (CFPS) technologies to streamline the creation of advanced protein-based biomaterials and reagents. The platform leverages AI-driven algorithms to optimize protein design and selection, while computer simulations predict protein behavior and interactions. CFPS technology enables rapid and efficient protein production, accelerating the development cycle. This integrated approach allows for the creation of high-quality proteins tailored for applications in early cancer diagnosis, personalized medicine, and novel drug discovery.
Target Audience
The primary target audience includes researchers and developers in the biomedicine sector focused on early cancer diagnosis, personalized medication guidance, and new drug development.
Features
- AI-driven protein design and optimization algorithms
- Computer simulations for predicting protein behavior and interactions
- Cell Free Protein Selective (CFPS) technology for rapid protein production
- Development of recombinant proteins, including T7 RNA polymerase, TNFα, and hyaluronidase
- Production of enzymes such as recombinant trypsin (mass spectrometry grade) and restriction endonucleases (e.g. BsLI)
- Manufacturing of specialized kits, including HRP rapid conjugation kits and Protein A residual detection ELISA kits
- Production of polymerases, including Direct Taq DNA polymerase and Hot Start Taq DNA polymerase
- Development of tissue digestion kits with recombinant collagenase and trypsin